These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 31209482)

  • 1. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.
    Hyman MC; Bao H; Curtis JP; Minges K; Schaller RD; Birgersdotter-Green U; Marchlinski FE; Hsu JC
    Heart Rhythm; 2020 Nov; 17(11):1878-1886. PubMed ID: 32497762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.
    Biffi M; Menardi E; Narducci ML; Ammendola E; Messano L; Giofrè F; Baiocchi C; Saporito D; Lissoni F; Bertini M; Pierantozzi A; Zingarini G; Malacrida M; Ziacchi M
    J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):968-975. PubMed ID: 29028784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after cardioverter-defibrillator replacement: Results of the DECODE survival score index.
    Zoni-Berisso M; Martignani C; Ammendola E; Narducci ML; Caruso D; Miracapillo G; Notarstefano P; Carinci V; Pierantozzi A; Ciaramitaro G; Calò L; Zennaro M; Infusino T; Ferretti C; Sassone B; Licciardello G; Setti S; Terzaghi C; Malacrida M; Biffi M
    Heart Rhythm; 2021 Mar; 18(3):411-418. PubMed ID: 33249200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy.
    Loughlin G; Avila P; Martinez-Ferrer JB; Alzueta J; Vinolas X; Brugada J; Arizon JM; Fernandez-Lozano I; García-Campo E; Basterra N; Fernandez De La Concha J; Arenal A
    Europace; 2017 Nov; 19(11):1818-1825. PubMed ID: 28339565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
    Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
    Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients.
    Bilchick KC; Wang Y; Curtis JP; Cheng A; Dharmarajan K; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; O'Connor C; Levy WC
    Am Heart J; 2020 Apr; 222():93-104. PubMed ID: 32032927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure.
    Echouffo-Tcheugui JB; Masoudi FA; Bao H; Spatz ES; Fonarow GC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure hospitalizations and costs in ICD/CRT-D recipients following replacement or upgrade: the DECODE registry.
    Zacà V; Narducci ML; Ziacchi M; Valente S; Pelargonio G; Tomasi C; Bandini A; Zingarini G; Calzolari V; Del Rosso A; Boggian G; Sabbatani P; Bonfantino MV; Malacrida M; Biffi M
    ESC Heart Fail; 2020 Dec; 7(6):4377-4383. PubMed ID: 32886455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.